How am I helping?
Your race fees and donations support The ROS1ders research fund.
Past race fees have helped to produce mouse models and cell lines created from leftover tissue donations from ROS1der patient biopsies. Mouse models and cell lines are used to study potential new treatment options for ROS1+ cancers. Since Amie's diagnosis in 2017, one new drug for ROS1+ cancer has received FDA approval.
The ROS1ders will be awarding seed grants to researchers in the fall of 2022 to start new studies that will be beneficial to ROS1+ cancer patients. You can read more about this project and the patient group, the ROS1ders, behind its evolution on the ROS1ders website.
Continued research provides additional treatment options for Amie and others like her. This is why your support matters!
Past race fees have helped to produce mouse models and cell lines created from leftover tissue donations from ROS1der patient biopsies. Mouse models and cell lines are used to study potential new treatment options for ROS1+ cancers. Since Amie's diagnosis in 2017, one new drug for ROS1+ cancer has received FDA approval.
The ROS1ders will be awarding seed grants to researchers in the fall of 2022 to start new studies that will be beneficial to ROS1+ cancer patients. You can read more about this project and the patient group, the ROS1ders, behind its evolution on the ROS1ders website.
Continued research provides additional treatment options for Amie and others like her. This is why your support matters!
